Skip to main content
FDA Shortage Check

Is Dexamethasone Sodium Phosphate Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Dexamethasone Sodium Phosphate…: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
DRUG
Dexamethasone Sodium Phosphate Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Feb 8, 2019
LAST FDA UPDATE
Oct 19, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 19 presentations: 4 unavailable · 0 limited · 15 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Dexamethasone Sodium Phosphate Injection. 19 presentations from 5 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Fresenius Kabi USA, LLC9 presentations · 3 unavailable · 6 available or not stated

Contact (FDA's listing): 888-386-1300

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)

    Next release January 2027. Check wholesalers for inventory.

    NDC 76045-0212-10Revised

    Unavailable

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)

    Next release January 2027. Check wholesalers for inventory.

    NDC 76045-212-10Revised

    Unavailable

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)

    Next release October 2026. Check wholesalers for inventory.

    NDC 63323-165-01Revised

    Unavailable

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)

    Check wholesalers for inventory

    NDC 63323-506-01Reverified

    Available

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)

    Check wholesalers for inventory

    NDC 63323-516-10Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)

    Check wholesalers for inventory

    NDC 63323-165-05Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)

    Check wholesalers for inventory

    NDC 63323-165-30Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10)

    Checkwholesalers for inventory

    NDC 76045-0210-10Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)

    Check wholesalers for inventory

    NDC 76045-210-10Reverified

    Available

Hikma Pharmaceuticals USA, Inc.3 presentations · 1 unavailable · 2 available or not stated

Contact (FDA's listing): 800-631-2174

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)

    Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe.

    NDC 0641-6145-25Revised

    Unavailable

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)

    Product will be made available as it is released.

    NDC 0641-0367-25Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)

    Additional product will be made available as it is released.

    NDC 0641-6146-25Reverified

    Available

Eugia US LLC1 presentation · 1 available or not stated

Contact (FDA's listing): 888-238-7880

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)

    Check wholesalers for inventory

    NDC 55150-304-25Reverified

    Available

Mylan Institutional, a Viatris Company4 presentations · 4 available or not stated

Contact (FDA's listing): 800-796-9526

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)

    NDC 67457-420-10Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)

    NDC 67457-421-30Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)

    NDC 67457-422-54Reverified

    Available

  • 4 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)

    NDC 67457-423-12Reverified

    Available

Somerset Therapeutics, LLC2 presentations · 2 available or not stated

Contact (FDA's listing): 732-554-1019

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)

    NDC 70069-021-25Reverified

    Available

  • 10 mg/1 mL

    Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)

    NDC 70069-025-10Reverified

    Available

What the manufacturers told FDA

  • Fresenius Kabi USA, LLC · ‘Next release January 2027. Check wholesalers for inventory.’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Next release October 2026. Check wholesalers for inventory.’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Dexamethasone Sodium Phosphate Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Dexamethasone Sodium Phosphate Injection as currently in shortage: 19 presentations, 4 unavailable and 0 limited.
When will the Dexamethasone Sodium Phosphate Injection shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Dexamethasone Sodium Phosphate Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.